2026-05-14: DEUSG Virtual

Meeting Details

Date & Time: 14th May 2026, 11am UTC

Objectives

Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Zoom Link

Link: DEUSG Zoom Meeting Link

Meeting Recording

Link:

Passcode:

Attendees:

Shane Byrnes, Monica Harry, Yongsheng Gao, Guillermo Reynoso, Ian Spiers, Jaya Sonavane, Jerry O’Sullivan, Julie Boutin, Laura Solana, Linda Bird, Nick McGraw, Nicki Ingram, Noelle Horan, Shane Doyle, Stuart Abbott, Tara Kelly, Wei Zhou.

Discussion items:

	Description	Mins	Owner	Notes & Actions

	Description	Mins	Owner	Notes & Actions
1	Opening	2 min	Shane	Welcome Notification of Recording & use of AI Meeting Format Update Proposal: Increase discussion time per topic in meetings (to support topic progression), and restart topic backlog.
2	DEUSG Group on Forums	2 min	Shane	Reminder to join to the DEUSG user group after you join forums - this allows you post and respond in the DEUSG category. Members - deusg - SNOMED Forums
3	Intended Site v Route of Administration - Carried from 30-04-26	5 min	Shane	Multiple perspectives on scope and implementation approaches across the group. Current pattern/approach will hold - allows focus on higher priority areas identified by group members. When a defining use-case arises we can work through options, and collate a business case for change.
4	Non - terminating strength rounding Carried from 30-04-26	5 min	Shane	Question to National Drug Extensions to confirm acceptance of rounding proposal and revert on the forums post: Non-terminating strength rounding Rules If the proposal is to be implemented as a standard set of rules, please let us know: If you agree with the proposal as a default set of rules, and would intend to adopt at national extension level. If you accept the proposal as a default set of rules, but don’t expect to adopt/doesn’t affect your extension. If the proposal actively causes issues for you at national extension level. We will collate the responses to a table to summarise the output of group members. In meeting: Topic will be discussed at meeting on Jun 11, 2026 with reframed approach.
5	Dose Form after Transformation	40 min	Yongsheng	In Meeting: Slide deck attached below.
6	AOB	5 min	All	In Meeting: Open question from UK if other countries are using ‘has product name’ relationship in extension models
7	Topic Backlog	5 min	All	Substances link to Organism Pending responses from members Product with no active ingredient / Inert Products In Meeting: Members to review and propose topics for backlog

Zoom AI generated summary of the meeting

Zoom AI generated summary of the meeting